基于TCMSP对玫瑰花黄酮和挥发油防治心血管疾病的协同作用及其机制研究

被引:34
作者
袁长胜
陈文
机构
[1] 石河子大学药学院
关键词
玫瑰花黄酮; 玫瑰花挥发油; TCMSP; 协同心肌保护;
D O I
暂无
中图分类号
R29 [中国少数民族医学];
学科分类号
100513 [民族医学];
摘要
为对芳香性维药玫瑰花黄酮和挥发油的协同心血管药理作用及机制进行探讨。利用中药系统药理学(TCMSP)工具和策略进行研究,建立玫瑰花黄酮和挥发油候选化合物库,利用Sys DT模型筛选二者作用靶点,并对其相关疾病进行映射,最后进行预测分析。结果显示,建立了玫瑰花黄酮和挥发油候选化合物库,并筛得了玫瑰花黄酮和挥发油的共同作用靶点7个。此外,黄酮高频作用靶点10个,挥发油高频作用靶点6个。通过疾病映射和分析发现,这些靶点都与心肌保护有一定的关系,挥发油的有些靶点还与血管舒缩活动有关。由此可知,根据预测结果,推断出玫瑰花黄酮和挥发油具有协同的心肌保护作用,为后续的玫瑰花药理作用的实验研究提供了一定的指导。
引用
收藏
页码:731 / 738
页数:8
相关论文
共 14 条
[1]
Systems Pharmacology Uncovers the Multiple Mechanisms of Xijiao Dihuang Decoction for the Treatment of Viral Hemorrhagic Fever.[J].Jianling Liu;Tianli Pei;Jiexin Mu;Chunli Zheng;Xuetong Chen;Chao Huang;Yingxue Fu;Zongsuo Liang;Yonghua Wang;Hyunsu Bae.Evidence-Based Complementary and Alternative Medi.2016,
[2]
Systems pharmacology to decipher the combinational anti-migraine effects of Tianshu formula.[J].Yan Li;Jingxiao Zhang;Lilei Zhang;Xuetong Chen;Yanqiu Pan;Su-Shing Chen;Shuwei Zhang;Zhenzhong Wang;Wei Xiao;Ling Yang;Yonghua Wang.Journal of Ethnopharmacology.2015,
[3]
A systems pharmacology approach to investigate the mechanisms of action of Semen Strychni and Tripterygium wilfordii Hook F for treatment of rheumatoid arthritis.[J].Yan Li;Jinghui Wang;Yuanchun Xiao;Yonghua Wang;Sushing Chen;Yinfeng Yang;Aiping Lu;Shuwei Zhang.Journal of Ethnopharmacology.2015,
[4]
Systems pharmacology-based approach for dissecting the addition and subtraction theory of traditional Chinese medicine: An example using Xiao-Chaihu-Decoction and Da-Chaihu-Decoction.[J].Bohui Li;Weiyang Tao;Chunli Zheng;Piar Ali Shar;Chao Huang;Yingxue Fu;Yonghua Wang.Computers in Biology and Medicine.2014,
[5]
Systems approaches and polypharmacology for drug discovery from herbal medicines: An example using licorice [J].
Liu, Hui ;
Wang, Jinan ;
Zhou, Wei ;
Wang, Yonghua ;
Yang, Ling .
JOURNAL OF ETHNOPHARMACOLOGY, 2013, 146 (03) :773-793
[6]
Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease [J].
Tao, Weiyang ;
Xu, Xue ;
Wang, Xia ;
Li, Bohui ;
Wang, Yonghua ;
Li, Yan ;
Yang, Ling .
JOURNAL OF ETHNOPHARMACOLOGY, 2013, 145 (01) :1-10
[7]
COX-2 inhibitors and cardiovascular risk [J].
Funk, Colin D. ;
FitzGerald, Garret A. .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2007, 50 (05) :470-479
[8]
A novel genetic model of selective COX-2 inhibition: Comparison with COX-2 null mice.[J].Ying Yu;Colin D. Funk.Prostaglandins and Other Lipid Mediators.2006, 1
[9]
基于系统药理学的现代中药研究体系 [J].
王永华 ;
杨凌 .
世界中医药, 2013, 8 (07) :801-808
[10]
离体培养人肠道菌群对芦丁代谢的研究 [J].
周鹏飞 ;
王建壮 ;
庞小雄 ;
吕华冲 .
广东药学院学报, 2011, 27 (06) :582-586